Lipocalin 2 is present in the EAE brain and is modulated by natalizumab

Detalhes bibliográficos
Autor(a) principal: Marques, Fernanda
Data de Publicação: 2012
Outros Autores: Mesquita, Sandro, Sousa, João, Coppola, Giovanni, Gao, Fuying, Geschwind, Daniel H., Columba-Cabezas, Sandra, Aloisi, Francesca, Degn, Matilda, Cerqueira, João, Sousa, Nuno, Neves, Margarida Correia, Palha, Joana Almeida
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/1822/21071
Resumo: The authors acknowledge the BiogenIdec, for providing Natalizumab (BiogenIdec, Boston, MA, USA). We are thankful to theCOST(European Cooperation in Science and Technology) Action NEURINFNETBM0603. We also thank Dr. Nadine Santos for critically reviewing this manuscript.
id RCAP_0272678491df1a6d6b121ee849998b9f
oai_identifier_str oai:repositorium.sdum.uminho.pt:1822/21071
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Lipocalin 2 is present in the EAE brain and is modulated by natalizumabMultiple sclerosisLipocalin 2Experimental autoimmune encephalomyelitisAstrocytes,Cerebrospinal fluidNatalizumabScience & TechnologyThe authors acknowledge the BiogenIdec, for providing Natalizumab (BiogenIdec, Boston, MA, USA). We are thankful to theCOST(European Cooperation in Science and Technology) Action NEURINFNETBM0603. We also thank Dr. Nadine Santos for critically reviewing this manuscript.Multiple sclerosis (MS) is a demyelinating disease that causes major neurological disability in young adults. A definitive diagnosis at the time of the first episode is still lacking, but since early treatment leads to better prognosis, the search for early biomarkers is needed. Here we characterized the transcriptome of the choroid plexus (CP), which is part of the blood-brain barriers (BBBs) and the major site of cerebrospinal fluid production, in the experimental autoimmune encephalomyelitis (EAE) mouse model of MS. In addition, cerebrospinal fluid samples from two cohorts of patients with MS and with optic neuritis (ON) were analyzed to confirm the clinical relevance of the findings. Genes encoding for adhesion molecules, chemokines and cytokines displayed the most altered expression, supporting the role of CP as a site of immune-brain interaction in MS. The gene encoding for lipocalin 2 was the most up-regulated; notably, the cerebrospinal fluid lipocalin 2 levels coincided with the active phases of the disease. Immunostaining revealed that neutrophils infiltrating the CP were the source of the increased lipocalin 2 expression in this structure. However, within the brain, lipocalin 2 was also detected in astrocytes, particularly in regions typically affected in patients with MS. The increase of lipocalin 2 in the cerebrospinal fluid and in astrocytes was reverted by natalizumab treatment. Most importantly, the results obtained in the murine model were translatable into humans since patients from two different cohorts presented increased cerebrospinal fluid lipocalin 2 levels. The findings support lipocalin 2 as a valuable molecule for the diagnostic/monitoring panel of MS.This work was supported by a grant from The Dana Foundation (USA) and by a grant from Fundação para a Ciência e Tecnologia(FCT, Portugal) (PIC/IC/83231/2007). Fernanda Marques and Sandro D. Mesquita are recipients of postdoctoral and doctoral fellow- ships from FCT, Portugal, respectively.Frontiers MediaUniversidade do MinhoMarques, FernandaMesquita, SandroSousa, JoãoCoppola, GiovanniGao, FuyingGeschwind, Daniel H.Columba-Cabezas, SandraAloisi, FrancescaDegn, MatildaCerqueira, JoãoSousa, NunoNeves, Margarida CorreiaPalha, Joana Almeida2012-11-292012-11-29T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/1822/21071eng1662-510210.3389/fncel.2012.00033info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T12:21:24Zoai:repositorium.sdum.uminho.pt:1822/21071Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T19:14:42.096316Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Lipocalin 2 is present in the EAE brain and is modulated by natalizumab
title Lipocalin 2 is present in the EAE brain and is modulated by natalizumab
spellingShingle Lipocalin 2 is present in the EAE brain and is modulated by natalizumab
Marques, Fernanda
Multiple sclerosis
Lipocalin 2
Experimental autoimmune encephalomyelitis
Astrocytes,
Cerebrospinal fluid
Natalizumab
Science & Technology
title_short Lipocalin 2 is present in the EAE brain and is modulated by natalizumab
title_full Lipocalin 2 is present in the EAE brain and is modulated by natalizumab
title_fullStr Lipocalin 2 is present in the EAE brain and is modulated by natalizumab
title_full_unstemmed Lipocalin 2 is present in the EAE brain and is modulated by natalizumab
title_sort Lipocalin 2 is present in the EAE brain and is modulated by natalizumab
author Marques, Fernanda
author_facet Marques, Fernanda
Mesquita, Sandro
Sousa, João
Coppola, Giovanni
Gao, Fuying
Geschwind, Daniel H.
Columba-Cabezas, Sandra
Aloisi, Francesca
Degn, Matilda
Cerqueira, João
Sousa, Nuno
Neves, Margarida Correia
Palha, Joana Almeida
author_role author
author2 Mesquita, Sandro
Sousa, João
Coppola, Giovanni
Gao, Fuying
Geschwind, Daniel H.
Columba-Cabezas, Sandra
Aloisi, Francesca
Degn, Matilda
Cerqueira, João
Sousa, Nuno
Neves, Margarida Correia
Palha, Joana Almeida
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade do Minho
dc.contributor.author.fl_str_mv Marques, Fernanda
Mesquita, Sandro
Sousa, João
Coppola, Giovanni
Gao, Fuying
Geschwind, Daniel H.
Columba-Cabezas, Sandra
Aloisi, Francesca
Degn, Matilda
Cerqueira, João
Sousa, Nuno
Neves, Margarida Correia
Palha, Joana Almeida
dc.subject.por.fl_str_mv Multiple sclerosis
Lipocalin 2
Experimental autoimmune encephalomyelitis
Astrocytes,
Cerebrospinal fluid
Natalizumab
Science & Technology
topic Multiple sclerosis
Lipocalin 2
Experimental autoimmune encephalomyelitis
Astrocytes,
Cerebrospinal fluid
Natalizumab
Science & Technology
description The authors acknowledge the BiogenIdec, for providing Natalizumab (BiogenIdec, Boston, MA, USA). We are thankful to theCOST(European Cooperation in Science and Technology) Action NEURINFNETBM0603. We also thank Dr. Nadine Santos for critically reviewing this manuscript.
publishDate 2012
dc.date.none.fl_str_mv 2012-11-29
2012-11-29T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/1822/21071
url http://hdl.handle.net/1822/21071
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1662-5102
10.3389/fncel.2012.00033
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Frontiers Media
publisher.none.fl_str_mv Frontiers Media
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799132590552121344